Co-occurrence of Bacterial Respiratory Pathogens in Children Under Five with Pneumococcal Carriage in Peninsular Malaysia - Report - MDSpire

Co-occurrence of Bacterial Respiratory Pathogens in Children Under Five with Pneumococcal Carriage in Peninsular Malaysia

  • By

  • Andrew Chun Hoong Tan

  • Nurul Hanis Ramzi

  • Nur Alia Johari

  • Pei Kuan Lai

  • Simone Wong

  • Xuan Qi Chang

  • Eileen Eng Jia Lin

  • Xin Ru Lum

  • Azim Haikal Md Roslan

  • Anna Marie Nathan

  • Cindy Shuan Ju Teh

  • Mohamad Ikram Ilias

  • Zakuan Zainy Deris

  • Asrar Abu Bakar

  • Muhd Alwi Muhd Helmi

  • Norhidayah Kamarudin

  • Lokman Hakim Sulaiman

  • February 12, 2026

  • 0 min

Share

Co-occurrence of Bacterial Respiratory Pathogens in Children Under Five

Overview

This study investigates the prevalence of pneumococcal co-carriage with other bacterial pathogens in children under five with pneumonia in Peninsular Malaysia. Findings indicate significant co-infection rates, highlighting the need for comprehensive diagnostic approaches in pediatric pneumonia management.

Background

Pneumonia is a leading cause of mortality in children under five, with various pathogens contributing to its etiology. In Malaysia, pneumonia accounted for 2.6% of deaths in this age group in 2023. Understanding the co-occurrence of bacterial pathogens is crucial for effective diagnosis and treatment, particularly as early colonization can predispose children to severe respiratory conditions.

Data Highlights

No numerical data available in the provided material.

Key Findings

  • The study involved 500 children under five diagnosed with pneumonia and 500 healthy controls.
  • Pneumonia cases were confirmed radiologically and clinically, ensuring accurate diagnosis.
  • Co-infections with other bacterial pathogens were assessed using multiplex qPCR analysis.
  • Previous studies have shown that SPN co-infection can lead to more severe clinical outcomes.
  • Monitoring pneumococcal co-carriage is essential for understanding the impact of vaccination programs.

Clinical Implications

Healthcare professionals should consider the potential for co-infections in children presenting with pneumonia. Rapid molecular diagnostic assays can aid in identifying multiple pathogens, which may influence treatment decisions and improve patient outcomes.

Conclusion

The study underscores the importance of recognizing co-infections in pediatric pneumonia, which may affect clinical management and outcomes. Ongoing surveillance is necessary to monitor the impact of vaccination on pneumococcal carriage and associated respiratory pathogens.

References

  1. Open Forum Infectious Diseases, 2023 -- Differential Impact of Pneumococcal Conjugate Vaccines on Hospitalized Versus Outpatient Community-Acquired Alveolar Pneumonia in Children Younger Than 5 Years Suggests Differences in Pathogenesis
  2. The Journal of Infectious Diseases, 2011-2019 -- Pneumococcal Carriage and Disease in Adults in England: The Importance of Adults as a Reservoir for Pneumococcus in Communities
  3. Open Forum Infectious Diseases, 2023 -- The Burden of Invasive Pneumococcal Disease and the Effects of 7- and 13-Valent Pneumococcal Conjugate Vaccines in Singaporean Pediatric Population Over 24 Years
  4. Infection, 2023 -- Inadequate Efficacy of Pneumococcal Vaccines Against Emerging Strains of Streptococcus pneumoniae Serotype 14/ST876
  5. Evidence and recommendations - Guideline on management of pneumonia and diarrhoea in children up to 10 years of age - NCBI Bookshelf
  6. Prevalence of pneumococcal carriage and risk factors for pneumonia and carriage among under-5 children in Malaysia: findings from the MY-Pneumo study | Pneumonia | Full Text
  7. IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age
  8. Evidence and recommendations - Guideline on management of pneumonia and diarrhoea in children up to 10 years of age - NCBI Bookshelf
  9. Prevalence of pneumococcal carriage and risk factors for pneumonia and carriage among under-5 children in Malaysia: findings from the MY-Pneumo study | Pneumonia | Full Text
  10. IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age

Original Source(s)

Related Content